CLDX FY2025 SEC EDGAR DEF 14A #123 of 168 in industry

Celldex Therapeutics, Inc. CEO pay ratio

The CEO earned $5.4M in FY2025 against median worker pay of $235,733 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#123/168

Data updated August 2026

Subscribe to Celldex Therapeutics, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
23:1
Below Average (Scale: 0–1000:1)
CEO pay
$5.4M
Median worker
$235,733

Answer first

Celldex Therapeutics, Inc.'s FY2025 CEO total of $5.4M ranks #899 of 1,423 complete filings; its 23:1 pay ratio ranks #1195. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $235,733. Industry placement uses the FY2025 SIC-28 peer cohort (# 123 of 168, 27th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#899
$5.4M of 1,423 FY2025
Ratio rank
#1195
23:1 of 1,423
Industry pct
27th
below the industry median pay ratio

How Celldex Therapeutics, Inc. ranks nationally

Celldex Therapeutics, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$5,421,859 37th percentile higher than 37% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Celldex Therapeutics, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($5.4M) against pay ratio (23:1) for Celldex Therapeutics, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both1865727.84015392.96165058.08314723.110464388.222.1:127.3:132.5:137.7:143.0:1CEO total payPay ratio (CEO : median worker)Celldex Therapeutics, Inc., CEO total pay: 5421859 · Pay ratio (CEO : median worker): 23:1Celldex Therapeutics, Inc.Kronos Worldwide Inc, CEO total pay: 2256576 · Pay ratio (CEO : median worker): 23:1Kronos Worldwide IncTravere Therapeutics, Inc., CEO total pay: 8457151 · Pay ratio (CEO : median worker): 23:1Travere Therapeutics, Inc.Schrodinger, Inc., CEO total pay: 4124521 · Pay ratio (CEO : median worker): 23:1Schrodinger, Inc.Nurix Therapeutics, Inc., CEO total pay: 6307796 · Pay ratio (CEO : median worker): 23:1Nurix Therapeutics, Inc.Axsome Therapeutics, Inc., CEO total pay: 10073540 · Pay ratio (CEO : median worker): 23:1Axsome Therapeutics, Inc.
Celldex Therapeutics, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Celldex Therapeutics, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Celldex Therapeutics, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
23:1
FY2025
vs prior FY
-16:1
from FY2024 39:1
CEO $ YoY
-41%
$5.4M latest
Filings shown
5
FY2021–2025
Celldex Therapeutics, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $6.0M - $195,006 31:1 -
2022 $5.4M -9.9% $194,578 28:1 -3:1
2023 $8.3M +53% $231,492 36:1 +8:1
2024 $9.2M +11% $236,393 39:1 +3:1
2025 $5.4M -41% $235,733 23:1 -16:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 744218, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
23:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$5.4M
Companies in Industry
168
vs. Industry Median
Below
#123 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Celldex Therapeutics, Inc.: near-parity Item 402(u) ratio

Celldex Therapeutics, Inc.'s FY2025 ratio 23:1 ranks #123 of 168 Chemicals & Pharmaceuticals filers (27th percentile). the CEO earned 23× the median employee ($235,733) in FY2025.

At $235,733 median worker pay, the FLOOR stamp is near pay-parity territory under MID$ CEO total.

CEO Total Pay

$5.4M

FY2025 Summary Compensation, below median

Pay Ratio

23:1

Below typical

Celldex Therapeutics, Inc. in the lower Chemicals & Pharmaceuticals third

Celldex Therapeutics, Inc.'s FY2025 ratio 23:1 ranks #123 of 168 Chemicals & Pharmaceuticals filers (27th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Celldex Therapeutics, Inc.'s $5.4M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #899 and ratio rank #1195 split - treat 23:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$5.4M
Median Employee Pay
$235,733
Pay Ratio
23:1
Filing Date
2026-04-29

Company Info

Ticker
CLDX
CIK
744218
Industry
Chemicals & Pharmaceuticals
SIC Code
2835
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 744218, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Celldex Therapeutics, Inc.'s FY2025 ratio 23:1 ranks #123 of 168 Chemicals & Pharmaceuticals filers (27th percentile).

Read with Celldex Therapeutics, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MID$ · ELITE-MED.

Agios Pharmaceuticals, Inc. · MID$

ABS(ceo_total_comp) peer at $5.5M (Δ $35K heavier vs Celldex Therapeutics, Inc.); FLOOR · ELITE-MED vs this page's FLOOR · MID$ · ELITE-MED.
Rayonier Inc · MID$

ABS(ceo_total_comp) peer at $5.5M (Δ $36K heavier vs Celldex Therapeutics, Inc.); MODEST · HIGH-MED vs this page's FLOOR · MID$ · ELITE-MED.
Summit Hotel Properties, Inc. · MID$

ABS(ceo_total_comp) peer at $5.5M (Δ $40K heavier vs Celldex Therapeutics, Inc.); MODEST · ELITE-MED vs this page's FLOOR · MID$ · ELITE-MED.
Treace Medical Concepts, Inc. · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $52K lighter vs Celldex Therapeutics, Inc.); MODEST · ELITE-MED vs this page's FLOOR · MID$ · ELITE-MED.
Kronos Worldwide Inc (SIC 28 pole)

Kronos Worldwide Inc stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Celldex Therapeutics, Inc.'s FLOOR filing.
National dual ranks · #899/#1195

Celldex Therapeutics, Inc.'s FY2025 package sits #899 by CEO dollars and #1195 by ratio under MID$ · FLOOR.
Ratio primer · FLOOR

Celldex Therapeutics, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Celldex Therapeutics, Inc. (CIK 744218), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.